Utilization of in vivo alkylated metabolites as a possible cause of increased sensitivity of tumor cells to alkylating agents (original) (raw)

Differences in the rate of destruction of alkylated RNA, protein, and lipid molecules in normal and tumor cells

Michael Lerman

Bulletin of Experimental Biology and Medicine, 1973

View PDFchevron_right

The development of metabolite transfer between reaggregating Novikoff hepatoma cells

Ross Johnson, Dale Pederson

Experimental Cell Research, 1980

View PDFchevron_right

Different degradation rates of alkylated RNA protein and lipids in normal and tumor cells

Michael Lerman

Cancer research, 1974

View PDFchevron_right

Major Differences between Tumor and Normal Human Cell Fates after Exposure to Chemotherapeutic Monofunctional Alkylator

Andy Tuck, Kandace Williams

View PDFchevron_right

The antitumour activity of alkylating agents is not correlated with the levels of glutathione, glutathione transferase and O6-alkylguanine-DNA-alkyltransferase of human tumour xenografts

Maurizio D'Incalci

European Journal of Cancer, 1998

View PDFchevron_right

Mice, men, mustards and methylated xanthines: the potential role of caffeine and related drugs in the sensitization of human tumours to alkylating agents

John P Murnane

British Journal of Cancer, 1981

View PDFchevron_right

Exposure of HeLa cells to 06-alkylguanines increases sensitivity to the cytotoxic effects of alkylating agents

Christopher Corsico

Biochemical and Biophysical Research Communications, 1985

View PDFchevron_right

The effects of bifunctional alkylating anti-tumor agents on oncogene structure and function in the human tumor cell line Colo 3320 HSR

Bernard Futscher

View PDFchevron_right

DNA damaging and cell proliferative activity of 1-methyl-1-nitrosourea in rat glandular stomach mucosa

C. Furihata

Mutation Research Letters, 1995

View PDFchevron_right

DNA alkylation in the hamster induced by two pancreatic carcinogens

Demetrius Kokkinakis

Cancer research, 1989

View PDFchevron_right

Effect of chlorambucil on synthesis of protein and nucleic acids in tumor-bearing mice

Sanchari Pradhan

Cancer research, 1960

View PDFchevron_right

Cytotoxicity of monofunctional alkylating agents. Methyl methanesulfonate and methyl-N'-nitro-N-nitrosoguanidine have different mechanisms of toxicity for 10T1/2 cells

Joe Grisham

Mutation research, 1983

View PDFchevron_right

Preclinical studies and clinical correlation of the effect of alkylating dose

Beverly Teicher

Cancer research, 1988

View PDFchevron_right

Alkyltransferase transgenic mice: probes of chemical carcinogenesis

Catherine Fan

Mutation Research-fundamental and Molecular Mechanisms of Mutagenesis, 1994

View PDFchevron_right

Accumulation of two alkylating agents, nitrogen mustard and busulfan, by murine leukemia cells in vitro

David Kessel

Biochemical Pharmacology, 1969

View PDFchevron_right

Early Modification of c-myc, Ha-ras and p53 Expressions by Chemical Carcinogens (DMBA, MNU)

Katalin Gombos, István Kiss, Ida Prantner, Timea Varjas

In Vivo, 2009

View PDFchevron_right

Formation and Antitumor Activity of PNU-159682, A Major Metabolite of Nemorubicin in Human Liver Microsomes

Marianna Fantin

Clinical Cancer Research, 2005

View PDFchevron_right

Biochemical Properties of Carcinogen-Metabolizing Enzymes in Cultured Hepatoma Cells

Umberto Marinari, Anna Maria Bassi

Toxicologic Pathology, 1987

View PDFchevron_right

1H MRS markers of tumour growth in intrasplenic tumours and liver metastasis induced by injection of HT-29 cells in nude mice spleen

Luis Lopez

NMR in Biomedicine, 1998

View PDFchevron_right

Histochemical profile of mouse hepatocellular adenomas and carcinomas induced by a single dose of diethylnitrosamine

Peter Bannasch

PubMed, 1991

View PDFchevron_right

O 6 -Methyguanine levels and histopathological changes in the rat esophagus and liver following single and repeated administration of N -nitrosomethylbenzylamin

Gary Stoner

Carcinogenesis, 1996

View PDFchevron_right

Changes in de novo DNA (cytosine-5-)-methyltransferase activity in oncogenically susceptible rat target tissues induced by N-methyl-N-nitrosourea

Annie Leszkowicz

Cancer research, 1986

View PDFchevron_right

S-adenosylmethionine in the chemoprevention and treatment of hepatocellular carcinoma in a rat model

Ryan Park

Hepatology, 2009

View PDFchevron_right

Carcinogen Induced Unscheduled DNA Synthesis in Mouse Hepatocytes

James Klaunig

Toxicologic Pathology, 1984

View PDFchevron_right

Mutagenicity, unscheduled DNA synthesis, and metabolism of 1-nitropyrene in the human hepatoma cell line HepG2

Priya Darshini

Cancer research, 1987

View PDFchevron_right

Antitumor Effect of the Mannich Base(1,3-bis-((3-Hydroxynaphthalen-2-yl)phenylmethyl)urea) on Hepatocellular Carcinoma

Ravikumar Sivanesan

Molecules (Basel, Switzerland), 2016

View PDFchevron_right

Early modification of c-myc, Ha-ras and p53 expressions by N-methyl-N-nitrosourea

Timea Varjas

In Vivo, 2008

View PDFchevron_right

Characterization of increased drug metabolism activity in dimethyl sulfoxide (DMSO)-treated Huh7 hepatoma cells

Susan Uprichard

Xenobiotica, 2009

View PDFchevron_right

Chemoprevention of hepatocarcinogenesis

Maria Simile

Alcohol, 2002

View PDFchevron_right

Mutagenic and chemotherapeutic activity in L1210 leukemia of several monofunctional alkylating agents

Bipin Mehta

Cancer research, 1985

View PDFchevron_right

The relationship of a novel drug-resistant phenotype in C3H10T1/2 cells selected with alkylating agents to neoplastic transformation and ATP metabolism

Eric von Hofe

Cancer Letters, 1997

View PDFchevron_right

Carcinogenesis and nucleic acid alkylation by some oxygenated nitrosamines in rats and hamsters

Joseph Saavedra

Chemico-Biological Interactions, 1988

View PDFchevron_right